Trials / Recruiting
RecruitingNCT03827694
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 400 (estimated)
- Sponsor
- Arkansas Children's Hospital Research Institute · Academic / Other
- Sex
- All
- Age
- 120 Days – 21 Years
- Healthy volunteers
- Not accepted
Summary
This study will establish a non-invasive diagnostic approach and evaluate clinical outcomes for children at high-risk for pulmonary invasive fungal infection (PIFI).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Non-Invasive Testing for PIFI | galactomannan assay, fungal PCRs, cell-free next-generation DNA/RNA sequencing, RNAseq |
Timeline
- Start date
- 2018-10-30
- Primary completion
- 2025-12-31
- Completion
- 2026-12-31
- First posted
- 2019-02-01
- Last updated
- 2024-09-25
Locations
33 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT03827694. Inclusion in this directory is not an endorsement.